{"id":"W2995889671","doi":"10.1016/j.jval.2019.09.2661","title":"PSY33 HTA REVIEW OF DECISIONS FOR PRODUCTS INDICATED IN THE TREATMENT OF SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) AND LUPUS NEPHRITIS (N) IN UK, GERMANY, FRANCE, ITALY, SPAIN, CANADA AND TURKEY","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"","funders":"","keywords":"Belimumab; Medicine; Lupus nephritis; Rituximab; Systemic lupus erythematosus; European union; Reimbursement; Disease; Dermatology; Immunology; Internal medicine; Lymphoma","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003494051,0.0003646744,0.000775738,0.002969601,0.000216975,0.001641597,0.0006181696,0.0009620682,0.009852456],"category_scores_gemma":[0.01075286,0.0002432918,0.001414235,0.004439608,0.0002925207,0.0007293456,0.0003454519,0.0009040914,0.0008571882],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.005412352,"about_ca_system_score_gemma":0.006732979,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.02825624,"about_ca_topic_score_gemma":0.04404762,"domain_scores_codex":[0.9981218,0.0007365026,0.0002855738,0.0001296966,0.0005895374,0.0001368408],"domain_scores_gemma":[0.9914315,0.004572458,0.001324792,0.0001021041,0.002315327,0.0002538858],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.001304575,0.00006762808,0.00451993,0.02058956,0.0008182892,0.0002860121,0.0001069228,0.003074459,0.0003398444,0.006493174,0.1873569,0.7750427],"study_design_scores_gemma":[0.0003147723,0.0003732467,0.05572686,0.03854501,0.001743324,0.0005194402,0.00028633,0.001042579,0.0006660871,0.001884308,0.8988456,0.000052392],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"empirical","genre_scores_codex":[0.005423272,0.9668674,0.00046482,0.008785311,0.001073156,0.00005900321,0.002352176,0.00002636189,0.01494846],"genre_scores_gemma":[0.08367438,0.8973643,0.001908641,0.004915073,0.001237011,0.00007986011,0.002399716,0.00003324252,0.008387718],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.9717438,"threshold_uncertainty_score":0.05618352,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04953274642682193,"score_gpt":0.2878147620450612,"score_spread":0.2382820156182393,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}